Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for ...

NV trading halted, news pendingDon't Miss our Black Friday Offers:Unlock your investing potential with TipRanks ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...

Mines Biomed, a molecular genetics diagnostic company, has entered into a collaborative agreement with Thermo Fisher ...

Mainz Biomed Announces Stock Split. BERKELEY, US and MAINZ, Germany – November 29, 2024 - Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular ...

Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in ...

Fintel reports that on November 25, 2024, HC Wainwright & Co. downgraded their outlook for Mainz Biomed N.V. (NasdaqCM:MYNZ) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Nasdaq Hearings Panel has given Psyence Biomed until December 31, 2024, to comply with the minimum bid price, market value of publicly held shares, and stockholders' equity requirements. During ...

Image: (left) Prof Christian Wolfrum will be appointed NTU's Deputy President and Provost-Designate from 2 Dec 2024. He succeeds Prof Ling San (right) who will step down from his role as Deputy ...